Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients.
about
Why the Treatment of Mental Disorders Is an Important Component of HIV Prevention among People Who Inject DrugsTreating depression within the HIV "medical home": a guided algorithm for antidepressant management by HIV cliniciansExcess burden of depression among HIV-infected persons receiving medical care in the united states: data from the medical monitoring project and the behavioral risk factor surveillance system.What is the relevance of mental health to HIV/AIDS care and treatment programs in developing countries? A systematic review.Do HIV-positive women receive depression treatment that meets best practice guidelines?Depression treatment enhances adherence to antiretroviral therapy: a meta-analysis.Factors associated with treatment initiation for psychiatric and substance use disorders among persons with HIVMental health treatment to reduce HIV transmission risk behavior: a positive prevention modelINtegration of DEPression Treatment into HIV Care in Uganda (INDEPTH-Uganda): study protocol for a randomized controlled trial.Antidepressant treatment and adherence to combination antiretroviral therapy among patients with AIDS and diagnosed depression.Benefits of family and social relationships for Thai parents living with HIV.Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient populationOne year after ART initiation: psychosocial factors associated with stigma among HIV-positive Mozambicans.Depression and poor adherence to lipid-lowering medications among patients with coronary artery diseasePredictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysisAntiretroviral therapy adherence among patients living with HIV/AIDS in ThailandScreening for hazardous alcohol use and depressive symptomatology among HIV-infected patients in Nigeria: prevalence, predictors, and association with adherence.What can mental health interventions contribute to the global struggle against HIV/AIDS?Persons newly diagnosed with HIV infection are at high risk for depression and poor linkage to care: results from the Steps Study.Validity of the Patient Health Questionnaire-9 to screen for depression in a high-HIV burden primary healthcare clinic in Johannesburg, South AfricaBenefits of adherence to psychotropic medications on depressive symptoms and antiretroviral medication adherence among men and women living with HIV/AIDS.Use of outpatient mental health services and psychotropic medications among HIV-infected patients in a multisite, multistate study.Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis.Retention in care and medication adherence: current challenges to antiretroviral therapy success.HIV patients with psychiatric disorders are less likely to discontinue HAART.Food Insecurity is Longitudinally Associated with Depressive Symptoms Among Homeless and Marginally-Housed Individuals Living with HIVA closer look at depression and its relationship to HIV antiretroviral adherence.The cost-effectiveness of counseling strategies to improve adherence to highly active antiretroviral therapy among men who have sex with menPersistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes.HIV-associated prospective memory impairment in the laboratory predicts failures on a semi-naturalistic measure of health care complianceChanges in HIV Outcomes Following Depression Care in a Resource-Limited Setting: Results from a Pilot Study in Bamenda, Cameroon.Health Outcomes of HIV-Infected People with Mental Illness.Prevalence and correlates of probable common mental disorders in a population with high prevalence of HIV in ZimbabweAssessing the effect of Measurement-Based Care depression treatment on HIV medication adherence and health outcomes: rationale and design of the SLAM DUNC StudyA Structured Protocol Model of Depression Care versus Clinical Acumen: A Cluster Randomized Trial of the Effects on Depression Screening, Diagnostic Evaluation, and Treatment Uptake in Ugandan HIV ClinicsSuicide mortality among people accessing highly active antiretroviral therapy for HIV/AIDS in British Columbia: a retrospective analysisMeasuring depression levels in HIV-infected patients as part of routine clinical care using the nine-item Patient Health Questionnaire (PHQ-9).Interaction study of the combined use of paroxetine and fosamprenavir-ritonavir in healthy subjects.The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review.Association between race, depression, and antiretroviral therapy adherence in a low-income population with HIV infection.
P2860
Q21284788-7E746365-CDD1-4724-AE08-2D9AE95975B0Q26823842-212377FB-6906-44F0-96F4-26935B34C0D4Q30210696-C7E36702-78C5-4683-BE5C-7C00C1D5E46AQ33570869-5E7621A4-E4BC-46A0-943D-22B50DF05BD1Q33610734-480CE294-AF7F-430E-8406-B8CC745A29FCQ33611057-146612E2-17DE-4E63-B4EB-C2530A9C99AAQ33649034-F5911D7C-4CC4-473A-BBFF-B391E7696C1DQ33716535-95F13405-AE76-4DFD-8EE8-91BDE7201DBCQ33851316-38B45280-CABC-4BBD-87FA-2DAC01E4BF30Q33902792-679FF9C6-3B61-492E-A019-042BA21948AAQ33926373-B2852907-DCE3-49AC-A68C-A57F18C49991Q33978708-858AB8A9-1966-4AF2-B8BB-FBFAF21D0243Q33981839-D44B646C-B922-498F-ADF3-42D3DF5E9CEBQ34056729-24508DC5-78E8-434E-AAF1-75505FE48132Q34103635-74F2CAE6-9A1C-4C48-9C3D-3CF13AE429ACQ34165125-61F43DA6-CD9E-49EE-BB54-D8BD3C146BE3Q34181703-AD2840D2-E418-4DDF-9511-7CE242DAFF80Q34482152-ACB664EA-4662-4535-B7B3-6E10588D7EF8Q34532722-AA6EF0B9-1CFD-4C66-846D-2E0559E573E2Q34684827-35ADF24A-95A9-4638-9DD5-9BCDA4B366AFQ34845860-F05D1727-077F-4578-B80D-862F9A3797FBQ35131523-A40B3164-A63A-4EFC-9E78-8F5A8C9F15CEQ35177350-083E0D4A-3F4C-43A5-8051-1FF4EDBF0148Q35257824-B8CD2951-FDB0-4058-9121-EB5AD7A0BF9FQ35545476-1DC990A0-CC18-459A-8036-797825DD213FQ35553818-4B4ADA2C-40A7-44F8-AE17-5B36701FEC10Q35580641-1CCC19C8-9F21-4E58-A9A0-7C2A400122E3Q35624701-CDFA4631-9355-40E1-9255-E63FC4F99B74Q35696271-F48FE239-49A0-42EF-9FFB-E936205C017DQ35711824-D6D319D9-1B1F-4C7D-B161-379B97FD1CE1Q35808253-E529F33C-2B03-4702-BA6D-CB5D974F905CQ35925058-E2EE777C-1456-4211-920F-AB72A974C255Q35939679-A70C0F08-E9E5-4322-B0F7-D04E1B6F3622Q35992064-A09A6901-65CF-4847-9D6D-5385E97FB503Q36014500-2953145D-05C5-4730-BB0A-FAAF7CC22CBEQ36045908-569962C9-7816-43F0-8B16-C3EB84875032Q36136578-AD1F4667-E37C-4451-9430-3431CFF75986Q36295441-FBA8D350-FCE4-4611-9EED-2815D90861D3Q36346957-CB3D2DDE-21CC-4F74-8C12-AC9359F9F467Q36447276-E0878152-B3D5-4C14-8BEB-552529EEED0C
P2860
Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Antidepressant treatment impro ...... pressed HIV-infected patients.
@ast
Antidepressant treatment impro ...... pressed HIV-infected patients.
@en
type
label
Antidepressant treatment impro ...... pressed HIV-infected patients.
@ast
Antidepressant treatment impro ...... pressed HIV-infected patients.
@en
prefLabel
Antidepressant treatment impro ...... pressed HIV-infected patients.
@ast
Antidepressant treatment impro ...... pressed HIV-infected patients.
@en
P2093
P1476
Antidepressant treatment impro ...... pressed HIV-infected patients.
@en
P2093
Arthur J Davidson
Joyce S Kobayashi
Lourdes W H Yun
Moises Maravi
Phoebe L Barton
P304
P356
10.1097/01.QAI.0000147524.19122.FD
P407
P577
2005-04-01T00:00:00Z